|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Revenue (Note 15) | |
| Depletion of royalty interests (Note 8) | |
| Gross profit | |
| General and administrative expenses (Note 16) | |
| Royalty generation expenses, net (Note 17) | |
| Share-based compensation expense (Note 14) | |
| Share of profit of associates (Note 9) | |
| Gains (losses) on disposals (Note 6, 9, and, 12) | |
| Impairment charges (Note 9) | |
| Profit from operations | |
| Other income and expenses | |
| Interest income | |
| Interest and finance expenses (Note 12) | |
| Gain (loss) on revaluation of financial instruments (Note 7 and 11) | |
| Foreign exchange loss | |
| Other income | |
| Income before income taxes | |
| Total income tax expense | |
| Profit (loss) from continuing operations | |
| Net loss of discontinued operations | |
| Total net income (loss) | |
| Other comprehensive income | |
| Gain on revaluation of digital currency (Note 7) | |
| Gain on revaluation of digital currency (Note 7) | |
| Foreign currency translation adjustment | |
| Other comprehensive income | |
| Total comprehensive income (loss) | |
| Income (loss) per share | |
| Continuing operations - basic (in dollars per share) | |
| Continuing operations - diluted (in dollars per share) | |
| Discontinued operations - basic (in dollars per share) | |
| Discontinued operations - diluted (in dollars per share) | |
| Weighted average number of common shares outstanding - basic (in shares) | |
| Weighted average number of common shares outstanding - diluted (in shares) |
Loading...
